EHA Library - The official digital education library of European Hematology Association (EHA)

FIVE YEARS OF HEMOVIGILANCE REPORTS OF COMPLICATIONS OF THE BLOOD DONATION REPORTED AT A TERTIARY CARE CENTRE IN KARACHI
Author(s):
Bipin Nepal
Affiliations:
Blood Bank,Grande International Hospital,Kathmandu,Nepal
(Abstract release date: 05/17/18) EHA Library. Nepal B. 06/14/18; 216801; PB2539
Dr. Bipin Nepal
Dr. Bipin Nepal
Contributions
Abstract

Abstract: PB2539

Type: Publication Only

Background

There is a minor chance of risk among blood donors. Even though blood donors are usually screened for the presence of risk factors, sometimes blood donations can put a person at panic.

Aims

The safety of the blood supply depends on the actions to protect both; blood transfusion recipient and the blood donor. Hemovigilance practice of learning of complications of blood donation and protecting them from such complications is the best way to minimize the risk to blood donor.

Methods

Comprehensive blood donor hemovigilance program was studied at Dr. Ishratul Ebad Khan Institute of blood diseases, Karachi from 2010 to 2015. Outlines of reported and communicated complications were collected after whole blood donation. Analysis was done by general logistic regression.

Results
Complications after 30,000 Whole blood donation procedures calculated1620total .(54 per 1,000 donations). The majority of the complications were faint and pre-faint reaction with light headedness (58.6 %), Sore arm (24 %), Bruises and hematoma (14.4 %). Minor complications were Agitation/sweating (2 %) and arterial puncture(1 %).  Markers of the complications were age, sex, race, weight, blood pressure and donation status. All associated independently after whole blood donation. Age and first-time status were associated with a significantly higher risk of complications with 18-22 years old at higher risk compared to 23 to 50 years old. First-time donor were at higher risk compared to repeat donor.

Conclusion

The results of this study are helpful in identifying and understanding the promoter to complication of blood donation. Donor age and status were strong predictors of complications. The remedies and specific areas of care should be provided.

Session topic: 32. Transfusion medicine

Abstract: PB2539

Type: Publication Only

Background

There is a minor chance of risk among blood donors. Even though blood donors are usually screened for the presence of risk factors, sometimes blood donations can put a person at panic.

Aims

The safety of the blood supply depends on the actions to protect both; blood transfusion recipient and the blood donor. Hemovigilance practice of learning of complications of blood donation and protecting them from such complications is the best way to minimize the risk to blood donor.

Methods

Comprehensive blood donor hemovigilance program was studied at Dr. Ishratul Ebad Khan Institute of blood diseases, Karachi from 2010 to 2015. Outlines of reported and communicated complications were collected after whole blood donation. Analysis was done by general logistic regression.

Results
Complications after 30,000 Whole blood donation procedures calculated1620total .(54 per 1,000 donations). The majority of the complications were faint and pre-faint reaction with light headedness (58.6 %), Sore arm (24 %), Bruises and hematoma (14.4 %). Minor complications were Agitation/sweating (2 %) and arterial puncture(1 %).  Markers of the complications were age, sex, race, weight, blood pressure and donation status. All associated independently after whole blood donation. Age and first-time status were associated with a significantly higher risk of complications with 18-22 years old at higher risk compared to 23 to 50 years old. First-time donor were at higher risk compared to repeat donor.

Conclusion

The results of this study are helpful in identifying and understanding the promoter to complication of blood donation. Donor age and status were strong predictors of complications. The remedies and specific areas of care should be provided.

Session topic: 32. Transfusion medicine

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies